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1 INTRODUCTION 
Cardiopulmonary Bypass (CPB) is one of the major technological 
advances in medicine. In this “whole body perfusion” method, the functions of the 
heart and the lungs are replaced temporarily with an extracorporeal circuit. Despite 
its complex structure, CPB needs to be absolutely safe, predictable and precise in 
terms of its performance. Although mortality of cardiac surgery has fallen, 
complications and morbidity associated with the use of cardiopulmonary bypass 
(CPB) still persist even after nearly 50 years of research, development and practice. 
CPB is associated with inflammatory response, mainly caused by surgical trauma, 
contact of the blood with the artificial surface of the circuit, ischaemia and 
reperfusion injury, resulting in increased capillary permeability, respiratory 
distress, low cardiac output, and multiorgan failure. Several equipment and 
techniques have been developed for ameliorating the damaging effects of CPB. 
Hence in an effort to avoid the adverse effects of CPB, Coronary Artery Bypass 
Grafting (CABG) without CPB "off-pump method” has been gaining popularity as 
an alternative to the conventional "on-pump" technique for myocardial 
revascularization. This includes Minimally Invasive Direct Coronary Artery 
Bypass (MIDCAB) and full sternotomy Off-Pump Coronary Artery Bypass 
(OPCAB) methods. Nevertheless, these techniques still remain a subject of dispute 
and controversies and the decline of MIDCAB seems evident. 
Respiratory problems are common after open heart surgery. The causes 
are multifactorial, but in general, the likelihood of respiratory difficulty depends 
directly on the patient's preoperative pulmonary function, the duration of CPB, and 
the cardiac performance after surgery. CPB alters the pulmonary function and 
morphology, but the exact pathogenesis of these changes is still not clear. The use 
of CPB predisposes some patients to acute respiratory failure, whereas in others, 
who already suffer from acute respiratory failure, long-term partial CPB sometimes 
improves lung function and therefore stands as a lifesaving modality. Theoretically 
based approach and investigation of the functional and structural alterations in the 
lungs during CPB is important for the following reasons: 
 
1. The heart and the lungs form an anatomical and functional 
unity with mutual effects on each other.  
2. Traditional open-heart surgery with the use of CPB often 
results in various pulmonary complications. 
3. Nowadays, cardiac surgeons often have to operate on 
patients with impaired lung function. 
4. Lung, and heart-lung transplantation, are widely accepted 
treatment modalities. 
 
  
2  AIMS OF THE THESIS 
 
The aim of this thesis has been to investigate the clinical, pathological 
and immune effects of cardiopulmonary bypass on the lungs during cardiac 
surgery. 
 
In my thesis I have tried to find the answers to the following questions: 
 
1. Nearly 50 years after the first use of CPB, what kinds of pulmonary 
complications occur and what is their incidence, following the use of 
CPB? 
 
2. With special emphasis on lung complications, does the dismissal of the use 
of CPB affect the development of postoperative complications? 
 
3. What histochemical changes are induced in the lungs by CPB? 
 
4. What correlations exist between the histochemical and the postoperative 
haemodynamical changes? 
  
3 MATERIALS AND METHODS IN GENERAL 
 
Altogether 822 patients have been involved in a complex retrospective, and 
81 patients in prospective study protocol that has consisted of various types of 
investigations. None of the involved patients has taken part in more than one kind 
of investigation. Only patients who had coronary artery revascularization have 
been involved in these studies. All but 7 patients had their operations performed on 
Cardiopulmonary Bypass. The clinical study protocols had been approved by the 
Hospital Ethics Committee. Verbal and written consent was requested from all 
patients before enrolling them in any investigation. All investigations complied 
with the rules of the Helsinki Declaration. 
 
3.1 Notes on surgery 
Median sternotomy and harvesting of the left internal mammary artery 
and of the saphenous vein occurred in all cases. In those CABG cases where CPB 
was applied, cannulation for CPB routinely involved the insertion of an arterial 
cannula into the ascending aorta and also the insertion of either one or two venous 
cannulas into the right atrium. Myocardial protection was achieved with antegrade 
crystalloid cardioplegia and by topical cooling with ice-sludge. In OPCAB cases 
the target coronary vessel was exposed, and the surrounding area was stabilised by 
a mechanical stabiliser. The target vessel was then snared proximal and distal to 
the chosen point for anastomosis. The coronary artery was then opened and the 
anastomosis performed. An intracoronary shunt was used only in the case of 
relative electrocardiographic or haemodynamic instability and excessive bleeding 
during the completion of the anastomosis.  
 
3.2 Notes on anaesthesia 
Anaesthesia was carried out intravenously in a similar manner with the 
use of midazolam, alfentanyl, propofol and pipecuronium. Priming solution of the 
CPB system consisted of the following: 1000 ml. Ringer lactate, 100 ml. Mannisol, 
100 ml. 20% Albumin (Biotest) and 60 ml. 8.4% sodium bicarbonate. CPB was 
performed with the use of core cooling to 34-35 oC and pulsatile flow of 2.4 l/body 
m2/minute. Coagulation was suspended with sodium-heparin in all cases. In a 
certain subgroup of patients, cardiac index, cardiac output, total peripheral 
resistance and pulmonary wedge pressure were also monitored with the use of the 
Swan-Ganz technique. 
 
  
3.3 Statistical analysis 
Because of the misleading effects of haemodilution in those operations 
performed on CPB, I have used the following equation for data correction:  
 
 
 
 
 
 
All data were analysed with the use of a statistical software program 
(SPSS, 7.5.1 SPSS Inc, Chicago, Ill.). Continuous and normally distributed data are 
presented as mean ± SD and were analysed with the use of variance analysis 
(ANOVA). Not normally distributed data are presented as median (interquartile 
range) and were analysed with the use of the Mann-Whitney U test for comparison 
between groups and the Wilcoxon sign ranks for comparison within groups. A 
probability value of less than 0.05 was regarded as statistically significant. In case 
of any special implications of the methods, further remarks will be devoted to the 
subject. 
 
 
4 ADULT RESPIRATORY DISTRESS SYNDROME FOLLOWING OPEN 
HEART SURGERY 
 
In this retrospective study, I have tried to delineate those perioperative 
factors that might contribute to the development of ARDS following open-heart 
surgery. 
 
4.1 Patients and methods 
Between November 1 1994 and October 31. 1997, 837 cardiac operations 
on CPB were performed in the Department of Cardiac Surgery of Zala County 
Hospital. Those patients who did not develop ARDS after surgery have served as a 
control group. With retrospective, statistical analysis, we have reviewed all data 
concerning the past medical history and the current operation. χ2 probe, Student t 
test and Mann-Whitney test were used for the analysis. I applied logistic regression 
analysis for the multivariate investigation. 
    
Blood sample concentration X starting haemoglobin value 
Corrected value =   
  Blood sample haemoglobin value 
4.2 Results 
 Based on data from the past medical history and from the pulmonologist’s 
opinion on examination, 46 patients (5.5%) had chronic obstructive, 44 (5.3%) had 
restrictive and 6 (1.3%) had mixed pulmonary disease preoperatively.  Table 1. 
represents the incidence of the main postoperative pulmonary complications. 
ARDS developed in 10 (1.2%) of the operated patients. One of these cases 
had a fatal outcome due to multiorgan failure added to ARDS. Autopsy findings 
justified and confirmed the clinical diagnosis in this patient. ARDS has not 
developed following mitral- and multiple valve replacement and repairs of 
congenital cardiac malformations. 
ARDS has proved more prevalent in patients suffering from COPD (2/46) 
and in the group of combined operations (2/67) however this difference between 
the study and control groups has not proved statistically significant. Those factors 
that have shown correlation with the development of ARDS on bivariate analysis 
are presented in Table 2. Regarding the postoperative variables, CPB duration 
along with the length of ischaemia and anaesthesia has proved longer in the ARDS 
group. 
 
Table 1.   Incidence of main postoperative pulmonary complications. 
 
Complication  Number of cases  %  
ARDS    10  1,2 
Pneumonia      9  1,1 
Embolism      3  0,35 
PTX    17  2,03 
Serious pleural effusion  15  1,8 
 
 
In that model where laboratory variables have also been taking in 
consideration (n=464), multivariate analysis has proved that pathologically 
elevated preoperative serum ASAT/ALAT and WBC count values were more 
common in the ARDS group (see the contents of Table 2.). Blood transfusion as a 
known risk factor has also been more prevalent in our patient population. 
Surprisingly enough however, significantly (p = 0,0002) more units of FFP were 
given to those patients who have subsequently developed ARDS. We have every 
reason to presume that FFP may stand as a serious independent risk factor. No 
similar data have been found in the literature. 
 
Table 2.   Correlation of postoperative ARDS with perioperative 
variables. 
 
Bivariate analysis ARDS Control P 
Preoperative WBC (106/ml)** 9,3 ± 0,9 6,8 ± 2,0 0,01 
Preoperative ASAT > 37 (U/l)* 40,0 6,4 0,003 
Preoperative LDH > 450 (U/l) * 40,0 9,2 0,019 
Anaesthesia time (minute)** 427 ± 104 337 ± 90 0,002 
Perfusion time (minute)** 165 ± 55 122 ± 62 0,028 
Ischaemic time (minute)** 101 ± 38 79 ± 34 0,049 
Postoperative RCB Transfusion 
( it)**
7,4 ± 4,1 4,3 ± 3,5 0,007 
Postoperative FFP Transfusion 6 3 0,0002 
Postoperative AMI * 40,0 6,5 0,0004 
Postoperative LCOS * 50,0 5,7 0,0000 
 
* % (χ2 test)     ** mean ± SD (T-test)    *** median (Mann-Whitney test) 
 
 
Table 3.   Correlation of postoperative ARDS with perioperative 
variables. "Logistic regression analysis" 
 
n = 464 B P 
Preoperative WBC (106/ml) 0,6355 0,0046 
Preoperative ASAT > 37 (U/l) 2,4021 0,0489 
Postoperative FFP transfusion (unit) 0,1662 0,0042 
Postoperative AMI 4,2085 0,0035 
CONSTANT - 9,3069 0,0001 
   
n = 833 B P 
Postoperative LCOS 2,8040 0,0000 
CONSTANT - 3,6427 0,0000 
  
Postoperative AMI has been seen more often in those cases with ARDS. This 
might be partially explained by the mutual aggravating effect of LCOS and AMI. 
On the basis of the above results I have justified that apart from the length of 
anaesthesia, CPB and ischaemic time, the volume of massive blood and FFP 
transfusion has shown strong correlation with the incidence of ARDS. Based on 
the multivariate regression analysis it can be concluded that this syndrome is also 
correlated with LCOS following open-heart surgery. 
 
 
 
5 OXIDATIVE STRESS IN THE LUNGS DURING CPB 
 
5.1 Patients and methods 
 
15 adult patients (13 males, 2 females) undergoing CABG were enrolled in 
this prospective study. The most important clinical data are shown in Table 4. 
 
Table 4.   Clinical data of enrolled patients. 
 
 Data Mean ± SD Range 
Age (years) 56.3 ± 11.1 40-72 
Body surface area (m2) 1.84 ± 0.2 1.55-2.12 
Body mass index (kg/m2) 27.2 ± 3.9 20.4-36 
Cross clamp time (min) 53.9 ± 16.6 45-106 
CPB time (min) 118.5 ± 22.3 62-147 
Mechanical ventilation time (hours) 8.5 ± 1.2 4-16 
No. of grafts 3.1 ± 0.7 2-4 
 
Spirometry was performed in all patients 2 days prior to surgery. All 
results of this investigation remained within the normal range. 
 
5.1.1 Study protocol 
The following biochemical substances were measured in blood samples taken 
from the radial artery and the left atrium: 
¾ Malondialdehid (MDA) 
¾ Reduced and Oxydated Glutathione (GSH-GSSG) 
  
¾ Myeloperoxidase (MPO) 
¾ Superoxide Dismutase (SOD) 
¾ Absolute neutrophil count 
¾ Stimulated radical production of isolated PMN  
 
5.1.2 Results 
Although statistically the changes were not significant but we experienced 
a mild decrease in the serum (starting value: 4 ± 3.4; 30th minute of ischaemia: 3.5 
± 1.5; 40th minute of ischaemia: 3.9 ± 2.3 IU/ml) and RBC (baseline value: 807 ± 
322; 40th minute of ischaemia: 700 ± 300; 5 minutes of reperfusion: 636 ± 241; 30 
minutes of reperfusion: 692 ± 346 IU/ml) SOD levels during ischaemia and 
reperfusion.  
Even 24 hours after surgery the RBC SOD content proved lower than the 
starting value (703 ± 352 IU/ml). The concentration values of MDA originating 
from red blood cells did not show any statistically significant change during 
surgery but they proved somewhat lower compared to the baseline value (starting 
value: 57.7 ± 26.7; 40 minutes ischaemia: 52.3 ± 23.3; 5 minutes reperfusion: 57.4 
± 24.9 nmol/ml). However 24 hours following surgery a significant increase could 
be detected in MDA values (79 ± 39.6 vs. 57.7 ± 26.7 nmol/ml at the beginning of 
the operation, p < 0.05). Plasma MDA values were found continuously and 
significantly increased during surgery (baseline value: 1.4 ± 0.7; 40 minutes 
ischaemia: 2 ± 0.9; 30 minutes reperfusion: 2.3 ± 1.1; 24 hours later: 2.5 ± 1 
nmol/ml). 
The GSH/GSSG ratio derived from the results of measurements in red 
blood cells has shown a contrasting pattern in the period of ischaemia and 
reperfusion. This ratio has decreased in the period of ischaemia (from 24 ± 6.3 to 
21.5 ± 11.3), indicating the presence of oxidative stress. These unfavourable 
changes have only come to an end by the conclusion of reperfusion, whilst 24 
hours after surgery the GSH/GSSG ratio has exceeded the baseline value (29.4 ± 
9.1). While the absolute value of neutrophil count measured in the pulmonary 
artery has shown a two-fold rise (baseline value: 3.1 ± 1.1 G/L; 40 minutes 
ischaemia: 6.1 ± 3.3 G/L) it has been first found decreased in the samples taken 
from the left atrium (baseline value: 3.1 ± 1.1 G/L, 30 minutes ischaemia: 2.5 ± 1.8 
G/L), then in the early reperfusion period it has been found suddenly increased 
again (20 minutes reperfusion: 5.3 ± 3.1 G/L). During ischaemia and reperfusion 
there has been a significant difference in the pre- and postpulmonary absolute 
neutrophil count in each case. The superoxide anion producing capacity of PMN 
cells has increased during the time of ischaemia, then, after the release of the aortic 
cross clamping it has been found drastically decreased (at the top of ischaemia: 
  
18.7 ± 4.9 early reperfusion: 3 ± 1,3 nmol O-2/min/1,5xl05 PMN). The changes have 
proved significant in both cases (p < 0.001).  
By the end of reperfusion the free radical producing capacity of PMN 
cells has returned to the values measured preoperatively, then it has risen again 24 
hours after surgery. At the same time MPO activity values have shown a 1,5-time 
rise compared to the baseline values at the end of ischaemia and during early 
reperfusion and these changes have proved statistically significant. No 
postoperative pulmonary complication has been experienced in any of the patients.  
 
5.1.3 Discussion 
The occurrence of oxidative stress after lung ischaemia and reperfusion 
has already been shown in animal experiments, but it is not yet well documented in 
humans during CPB condition.  
In this study, I have found neutrophil gradient through the lungs in the 
prepulmonary (pulmonary artery) and postpulmonary (left atrium) blood samples 
in the ischaemic and in the early reperfusion period. This phenomenon has 
indicated that a considerable amount of neutrophil cells has migrated and trapped 
into the lung tissues due to ischaemia. The superoxide anion producing capacity of 
PMN cells has clearly demonstrated the ischaemic and reperfusion injury -affecting 
the lungs as well- taking place during surgery. It has been notable that at the early 
stages of reperfusion the superoxide producing capacity of PMN cells has come 
back to normal values for a short term. I assume that this is due to the „wash out” 
phenomenon. The MPO enzyme that can be found in large quantities in neutrophil 
granulocytes and which facilitates reactions producing various reactive 
intermediates appears in the serum under pathologic conditions. Thus a rise in the 
level of MPO has been found suggestive of PMN activation and of an increase of 
the free radical reaction as well. Summing up our results I may draw the following 
conclusions: A large quantity of neutrophil cells migrate into the lungs during heart 
surgery on CPB due to ischaemia. I have justified the activity of these neutrophils 
by the detection of the increased superoxide radical producing capacity and of the 
increased release of MPO. Based upon what stated above one can claim that 
increased cell activation and pathologic free radical reactions in the lungs should 
be taken in account in cardiac operations on CPB. Changes of malondialdehid, 
reduced and oxydated glutathion levels confirm the above statement. In our patient 
population no serious clinical pulmonary complication has occurred 
postoperatively, but this fact must not refute our assumption that it is the free 
radical reactions that serve as a basis for the pulmonary complications occurring in 
the postoperative period. 
  
6 LACTATE PRODUCTION BY THE LUNGS DURING CPB 
 
Theoretically, the detection of excessive pulmonary lactate production 
could help grade the severity of lung disease or injury, but these measurements are 
fraught with technical difficulties. During CPB, pulmonary artery blood flow is 
either completely or partially shut off and the lungs are mostly perfused by the 
bronchial flow. This potentially leads to lung ischaemia that depletes the energy 
stores of the lung tissues.  
In the following prospective study I sought to determine whether the lungs 
release lactate in humans during CPB.  
 
6.1 Patients and methods 
In this study I measured lactate concentrations across the lungs in 23 
patients who underwent CABG surgery with the use of partial, normothermic CPB. 
The main data of the patients are summarised in Table 5. 
 
Table 5.   Enrolled Patient's data. 
 
N:     23 
Male/Female:     17/6 
Mean age:    60 ± 8.8 years 
Mean aortic cross clamp time:   58 ± 9 min. 
Mean CPB time:     89 ± 15 min. 
Mean graft number:   3.11 ± 0.9 
Mean ejection fraction (EF)  48.7 ± 11.3 % 
AMI:     20/23 
COPD:     9/23 
 
 
Cardiopulmonary functions were measured by thermodilution immediately before 
CPB, 10 minutes, 2 and 24 hours after CPB cessation. 
 
6.1.1 Results 
I have found that lactate concentration in the arterial (left atrium), and in the 
mixed venous blood (pulmonary artery) was significantly increased 5 minutes after 
aortic cross clamping. In the arterial blood it was raised from 1.18 (0.75-2.11) to 
3.31 (1.62-5.03) mmol/l (p < 0.001) and in the mixed venous blood from 1.21 
(0.92-1.99) to 3.07 (1.98-5.12) mmol/l (p< 0.001). However, lactate concentration 
  
in the arterial blood slightly exceeded those values found in the mixed venous 
blood. Lactate ratio figures were constantly increased during the ischaemic period 
and they were significantly higher compared to the value of baseline ratio. Ten 
minutes after the release of the aortic cross clamping the ratio returned to the 
baseline value. Two hours after the cessation of CPB lactate concentration reached 
another peak in both of the arterial and venous blood samples, 3.21 (1.29-6.68) 
mmol/l and 3.04 (1.11-6.96) mmol/l consecutively, but the ratio remained 
unchanged. 
 
 
Table 6.   Median values of lactate concentrations  
 
Sample Postpulmonary blood 
samples 
Median (range) 
Prepulmonary blood 
samples 
Median (range) 
 
P 
S1 1,18 (0,75 – 2,11) 1,21 (0,92 – 1,99) Ns 
S2 3,31 (1,62 – 5,03) 3,07 (1,98 – 5,12) Ns 
S3 3,02 (1,82 – 4,83) 2,66 (1,47 – 5,02) < 0,006 
S4 3,13 (1,66 – 4,58) 2,16 (1,31 – 3,51) < 0,003 
S5 2,96 (1,60 – 4,81) 2,18 (1,45 – 4,22) < 0,019 
S6 2,37 (1,41 – 4,34) 2,13 (1,21 – 4,96) Ns 
S7 1,92 (1,19 – 2,94) 1,88 (1,16 – 2,50) Ns 
S8 3,21 (1,29 – 6,68) 3,04 (1,11 – 6,96) Ns 
S9 1,99 (1,59 – 7,38) 2,11 (1,43 – 7,16) Ns 
 
I have found a correlation between body weight and the maximal value of 
lactate ratio (S4) (0,627 p=0.039). The lactate ratio of those patients with COPD 
has proved higher after the release of aortic cross clamping compared to the rest of 
the patients 1,56 vs. 1,15; however the difference has not proved statistically 
significant (p = 0,055). Lactate values in blood samples taken from the pulmonary 
artery following aortic cross clamping (S2, S3) have shown positive correlation 
with the amount of blood transfusion given during the operation (0,56 p= 0,047 in 
both cases). SV and CI measured 2 hours after the cessation of CPB have shown a 
strong and negative correlation with the lactate values measured during the aortic 
cross-clamping period. 
  
7 ROLE OF THE LUNGS ON THE ALTERATIONS OF CYTOKINES 
DURING CPB 
 
The purpose of this study has been to investigate the fluctuation in cytokine 
production, during and after CPB and to define whether the lungs produce or 
consume inflammatory mediators under this clinical condition. The other goal has 
been to assess the influence of these mediators on the postoperative haemodynamic 
status. 
 
7.1 Patients and methods 
13 consecutive patients (10 males, 3 females) undergoing CPB for 
elective CABG were prospectively entered into this study. Exclusion criteria were 
as follows: patients with renal failure, patients with a history of, either obstructive 
or restrictive pulmonary disease and patients with any kinds of immune disease. 
Before the induction of anaesthesia, a Swan-Ganz thermodilution catheter 
(Corodyn TD-I Touch-Free 7.5 F; B. Braun Medical Inc., Bethlehem PA USA) and 
an 18 G radial artery catheter were inserted in order to obtain haemodynamic and 
oxygen transport parameters. The haemodynamic parameters were studied in the 
following five time intervals: 
 
M1:  before anaesthesia induction 
M2:  before start of CPB 
M3:  10 minutes after CPB cessation 
M4:  2 hours after CPB cessation 
M5:  24 hours after CPB cessation 
 
Pulmonary arterial and left atrial blood samples were obtained simultaneously.  
TNF-α, IL-2, IL-6, IL-8 and IL-10 levels in the plasma were determined 
in the collected samples by means of commercially available enzyme linked 
immunosorbent assays (ELISA). Different types of leukocyte counts as well as the 
transpulmonary cytokine gradient were measured.  
Because comparisons were made between paired samples, with each 
patient serving as his or her own control, and because the data were not normally 
distributed, the concentration figures of cytokines were presented in median and 
were compared to the baseline values with the Wilcoxon signed-rank test. Data of 
the pre- and postpulmonary blood samples were compared with the Mann-Whitney 
U test. Correlation between peak values, and different parameters were assessed by 
Spearman’s rank correlation coefficient. 
 
  
7.2 Results 
Morphometric and demographic characteristics, preoperative 
cardiopulmonary function, and the duration of surgery are shown in Table 7. 
Although pH and PaO2 decreased at the end of surgery, the other hemodynamic 
and respiratory measurements did not differ significantly over time (Table 8). In 
both the arterial and venous blood samples the number of plasma leukocytes 
increased significantly, with the percentage of neutrophil and monocytes increasing 
and the percentage of lymphocytes decreasing significantly over time.  
 
Table 7.   Main clinical data. 
 
  Mean ± SD Range 
Age (years) 61.6 ± 8.5 46 – 75 
Body surface area (m2) 1.87 ± 0.2 1.48 - 2.15 
Body mass index (kg/m2) 27.2 ± 3.9 19.6 - 35.3 
FVC (% predicted) 98 ± 12 67 - 128 
FEV1 (% predicted) 82 ± 6 70 - 95 
Cross clamp time (min) 68.8 ± 15.8 41- 102 
CPB time (min) 124.5 ± 29.3 60 -167 
Mechanical ventilation time (hours) 9.2 ± 4 5 - 17 
No. of grafts 3.4 ± 0.8 2 - 5 
 
 
Table 8.   Intraoperative data. 
 
  Beginning End 
Mean arterial pressure (mmHg) 92 ± 9 90 ± 11 
Heart rate (bpm) 77 ± 9 86 ± 9 
Central venous pressure (cm H2O) 7.9 ± 2.3 7.8 ± 2.7 
Cardiac index (L*min-1*m-2 2.6 ± 0.2 2.8 ± 0.4 
Oesophageal temperature (oC) 36.5 ± 0.3 36.3 ± 0.5 
Arterial pH 7.41 ± 0.04 7.38 ± 0.04 
Arterial PCO2 (mmHg) 39 ± 3 40 ± 2 
Arterial PO2 (mmHg) 475 ± 35 328 ± 88 * 
Activated clotting time (s) 133 ± 24 144 ± 32 
 
 
  
TNF-α and IL-2 could only be detected in six patients at all. All IL-2 values have 
remained within the normal range. TNF-α levels did not show any significant 
variation in the pulmonary or systemic circulation, values above the normal range 
could only be detected in two patients, however these elevated values did not show 
any correlation with the patients’ clinical condition. In both the arterial and venous 
blood samples the concentrations of IL-6, IL-8 and IL-10 increased significantly 
during the investigation period and reached a peak 2 hours after the cessation of 
CPB.  
The concentration of IL-6 has proved somewhat higher in the left atrium in 
samples S2, S3 and S4 compared to those values measured in the pulmonary 
arterial samples, however this difference has not been statistically significant. 
(Table 9) 
 
 
Table 9.   Values of IL-6.  
 
Sample Postpulmonary blood 
Median (range) 
Prepulmonary blood 
Median (range) 
P 
S1 1.7 (0.4-13.5) 1.6 (0.4-12) 0.84 
S2 14.3 (1.4-52.8) 10.4 (1-56.9) 0.38 
S3 19.7 (2.5-71.5) 16.6 (3.1-75.2) 0.59 
S4 26.5 (2.4-91.1) 20.2 (3.3-88.5) 0.72 
S5 35.9 (8.5-309.5) 37 (10-286.4) 0.49 
S6 60.8 (18.3-271.3) 61.5 (16.1-300) 0.36 
S7 79.2 (14.6-160.4) 84 (17.6-155.2) 0.31 
S8 112 (25.3-216.9) 117.3 (22.7-195.5) 0.22 
S9 38.2 (16.8-177.6) 39.1 (15.7-182) 0.55 
 
24 hours after the operation the level of IL-8 returned to the baseline. The ratio of 
IL-8 concentration showed a biphasic pattern (figure 6). In the ischaemic and in the 
early reperfusion period (time course between 3rd and 7th blood samples) the ratio 
equalled less than 1,0. Following CPB the ratio equalled more than 1,0. However 
only 10 minutes after the release of the aortic cross clamp the concentration of IL-8 
in the venous blood 71.21 (9.2-411.2 pg/ml), was significantly higher than the 
concentration in the arterial blood 41.4 (8-127.8 pg/ml). 
 
Concentrations of IL-10 in the venous blood samples were higher than the 
concentration in the arterial blood samples and this difference was significant in 
samples S2, S3, S4, S5 (see table 10) 
 
 
  
 
Table 10.   Values of IL-10.  
 
 
Sample Postpulmonary blood 
Median (range) 
Prepulmonary blood 
Median (range) 
P 
S1 2.1 (0.8-8.3) 2.9 (1.3-10.8) 0.074 
S2 8.7 (0.7-104.6) 13.22 (1.8-102.1) 0.041 
S3 9 (0.8-118.1) 23.5 (1.4-127.5) 0.007 
S4 23.1 (3.2-141.9) 32.1 (3.7-222.2) 0.003 
S5 66.5 (11.9-314.9) 96.1 (17.2-402.5) 0.01 
S6 105.8 (18.5-545.8) 119.5 (18.3-574.6) 0.055 
S7 113.6 (15.9-533.5) 114.9 (15.9-516) 0.42 
S8 61.7 (20.4-227.9) 62.8 (19.2-330) 0.51 
S9 8 (3.1-40.9) 9.5 (4-59.1) 0.13 
 
I have found a correlation between the peak values of IL-6, IL-8, IL-10 and 
the duration of CPB (0.69  p = 0.02; 0.71  p= 0.001; 0.72  p = 0.028 respectively), 
but not with the aortic cross clamp time.  
The value of pulmonary vascular resistance (PVR) measured in the 2nd hour 
(M4) following the cessation of CPB has shown a negative correlation with the IL-
6 value measured in the pulmonary artery (S6) after the cessation of CPB: (-0.616;  
p = 0.033).  
The value of left ventricular stroke work index (LVSWI) measured in the 
2nd hour (M4) following the cessation of CPB has shown a correlation with the IL-
10 values measured in samples (S8) from the radial and from the pulmonary artery. 
Correlation values were: 0.65; p = 0.022 and 0.64; p = 0.03 respectively. Values of 
S7 from the left atrium and from the pulmonary artery have shown a negative 
correlation with the mechanical ventilation length: - 0.71 p = 0.007 and – 0.65 p = 
0.02 respectively.  
 
7.3 Discussion 
Numerous clinical studies have shown significant elevation of blood 
cytokine levels during and after CPB. Such a phenomenon can be induced by 
several factors, including ischaemia-reperfusion, complement activation, and 
release of endotoxin. The release of proinflammatory cytokines may be important 
because such a release seems to be implicated in the development of postoperative 
complications. Advances in knowledge about the interactions of cytokines 
involved in the response to CPB may lead to new therapeutic implications which 
could improve the outcome of patients undergoing cardiac surgery. Administration 
  
of anti-IL-8 antibodies prevents lung ischaemia-reperfusion injury in rabbits. Anti-
TNF antiserum may reduce pulmonary and hepatic injury caused by hepatic 
ischaemia-reperfusion. Removal of TNF-α and IL-6 by hemofiltration has been 
shown to have beneficial effects in children undergoing CPB. Administration of 
steroids before CPB not only reduces significantly the release of proinflammatory 
cytokines but also increases the release of IL-10. 
For better insight into the pathophysiology involved, it is important to 
identify the primary source of these cytokines. There are, however few reported 
data indicating the resource organ of these cytokines in patients undergoing CPB. 
To study lung contribution to the release of cytokines I compared lung specific 
cytokine concentrations in plasma samples taken from blood space immediately 
before, and after the lungs. 
TNF-α may play an important role in the inflammatory response after 
CPB, not only because it may directly induce some symptoms, such as fever, 
tachycardia, and hypotension, but also because it may trigger the release of other 
important cytokines, such as IL-8, and IL-10. Although many have already 
justified the role of TNF-α in the inflammatory response, I have not been able to 
obtain a clear-cut view on the kinetics of TNF-α. Presumably, this could happen 
due to the short half-life and to the locally acting nature of the TNF-α. It would 
have been much more efficient to measure the TNF-α levels in the lung tissues. 
The investigation of the soluble receptors of TNF-α seems more promising since 
these mediators offer a more sophisticated picture on the inflammatory response. 
These receptors are still to be studied in further investigations in my department. 
With respect to IL-2, this study could not prove any serious changes in IL-
2 concentrations during CPB. Previous studies reported a decrease of IL-2 and IL-2 
receptor expression directly after the start of CPB. However it seems that IL-2 does 
not have a leading role in the inflammatory response during CPB. 
IL-6 is a good marker of injury severity even though it does not have toxic 
effects itself. IL-8 is a crucial mediator in ischaemia-reperfusion injury in patients 
undergoing CPB. IL-8 release is induced only after reperfusion of the ischaemic 
myocardium in animals as well as in human beings.  
I found that the plasma levels of IL-6, IL-8 and IL-10 increase 
significantly in the first hours after surgery. I could prove a positive correlation 
between the magnitude of the examined cytokines response to CPB and the 
duration time of the extracorporeal circulation, but not the duration time of the 
aortic cross-clamp. Moreover my observed data indicate that the lungs are not 
predominant sources of IL-6 and they may rather consume than release IL-8 and 
IL-10 during CPB.  
The tissue source of the antiinflammatory cytokine IL-10 under CPB still 
needs to be determined. In this study IL-10 shows a positive correlation with 
  
favourable haemodynamic variables. The experienced phenomenon perhaps 
verifies the protecting effect of IL-10. My data do not exclude significant cytokine 
release by other organs. In fact, other organs also have inadequate blood supply 
during CPB and could similarly be important sources of mediators. Furthermore, 
the release of endotoxin frequently observed during CPB, as well as complement 
activation, may trigger the release of cytokines. 
 
 
8 ADHESION MOLECULES IN PATIENTS UNDERGOING CORONARY 
ARTERY REVASCULARIZATION 
 
8.1 Patients and methods 
12 adult patients (mean age: 59.4 ± 7.2 years) undergoing coronary 
revascularization surgery requiring the use of CPB have been enrolled in this study 
(group A). There have been 5 patients (mean age: 59.1 ± 11.2 years) in the control 
group whose coronary surgery did not require the use of CPB (group B). 3 grafts 
were carried out in 1 patient (to LAD, CX, RC coronaries), 2 grafts in 3 patients (to 
LAD, CX or RC coronaries), and 1 graft in 1 patient (to LAD coronary artery) 
during off pump surgery. The main clinical data are shown in Table 11. 
 
Table 11.   Patients’ clinical data 
 
 
 Group A Group B 
Case No. 12 5 
Gender (male/female) 9/3 4/1 
Mean age (years) 59.4 ± 7.2 59.1 ± 8.6 
Mean aortic cross clamp time (minutes) 52 ± 6 0 
Mean CPB time (minutes) 89.7 ± 18.3 0 
Mean mechanical ventilation duration (hours) 7.8 ± 4 6.3 ± 1.5 
Mean ICU stay (hours) 43.5 ± 5 40 ± 6 
Mean number of grafts 3.23 ± 0.7 2 ± 0.8 
 
Serial blood samples were taken from the central venous line. Since the method of 
surgery differed in the two groups, we made our best efforts so that the blood 
samples be taken at the same times in both groups.  
At the same time samples added to EDTA were taken for haemoglobin, 
haematocrit and WBC count. Those blood samples for the analysis of serum levels 
  
of soluble molecules were immediately centrifuged in a cooled centrifuge system. 
(20 min., 4000/minute revs.) After this, the samples were stored on –20
o
C 
temperature until the analysis. The blood samples were analysed within 4 weeks 
for soluble ICAM-1 (normal average value: 211 ng/ml, ± 2 SD, reference: 115-306 
ng/ml) and for soluble E-selectin (normal average value: 46 ng/ml SD, reference: 
29-63 ng/ml). The analysis was carried out with the ELISA method (R&D Systems 
Inc. Minneapolis, USA) 
The principle of the measurement is the reaction of the adhesion molecules with 
two monoclonal antibodies directed against the various epitops on the surface of 
the adhesion molecules. All measurements were standardised by reactions against 
either purified recombinant ICAM-1 or E-selectin. The sensitivity (minimal 
detectable dose) to E selectin and ICAM-1 proved <1.0 ng/ml and <0.35 ng/l 
respectively. All results are calculated from the average of two different 
measurements. The serum levels of circulating adhesion molecules were calculated 
by the use of simultaneous standard charts. In those operations requiring CPB, 
errors due to haemodilution were corrected as mentioned previously. Normally 
distributed data are presented as mean ± SD and were analysed with the use of 
variance analysis (ANOVA). Not normally distributed data are presented as 
median (interquartile range) and were analysed with the use of the Mann-Whitney 
U test for comparison between groups and the Wilcoxon sign ranks for comparison 
within groups. Differences have been regarded significant if the value of p has 
proved <0.05. 
 
8.2 Results 
No complications occurred and no reoperations were necessary in those 
patients enrolled in the study. The mean length of ICU stay has proved less than 48 
hours similarly in both groups.  
Neutrophil count has raised significantly in both groups. However, this elevation 
proved more pronounced in group A. A four-fold raise could be detected in group 
A 24 hours following surgery and the figures remained the same throughout the 
next two days. A significant difference could be detected between the two groups 
in samples 5, 7, 8, 9 and 10. 
There has been no explicit change in the level of serum ICAM-1 and E 
selectin in those operations without CPB neither during nor after surgery. The 
figures of serum ICAM-1 and E selectin in blood samples taken in different points 
of time have remained within the normal range from first to last. 
In group A however I have found a significant fall in the serum levels of 
both the ICAM-1 and E-selectin during the cross clamp period. Following the 
correction of the effects of haemodilution the decrease could still be seen but has 
already not proved statistically significant. 24 hours after CPB the measured serum 
  
level of ICAM-1 has increased by 76% compared to the starting figure, from 193.8 
(148.7-254.3) ng/ml to 340.9 (239.1-404) ng/ml, (p < 0.002). 48 hours after 
surgery the average value of ICAM-1 has been found slightly decreased but it has 
still remained significantly higher compared to the starting figure; 193.8 (148.7-
254.3) vs. 279.8 (208.8-382.4) ng/ml, (p < 0.002). 72 hours after surgery the serum 
level of ICAM-1 has come down close to its original starting value 192 (156.4-
242) (Figure 23) The serum levels of E selectin have shown a trend similar to that 
of ICAM-1. The baseline median value of E-selectin was 31.1 (20.9-53.3) ng/ml 
and it have reached its peak 24 hours after CPB 44.8 (30.9-58.8) ng/ml. This 
change has proved statistically significant to the baseline value. (p<0.003). The 
comparison of the measurements made at similar points of time in the two groups 
is shown in Table 12. 
 
Table 12.   Median values of E-selectin and ICAM-1 in the two groups in 
nearly coinciding times.  
 
E-selectin ICAM-1 Sample 
Group A Group B  
 
P Group A  Group B  
 
P 
1 31.1 
(20.9-53.3) 
29.2 
(26.1-39.7) 
Ns 193.8 
(148.7-254.3) 
189.2 
(168.5-219.4) 
Ns 
3 18.9 
(12.7-31.4) 
25.3 
(22.3-36.3) 
* 136.1 
(115.4-197.3) 
198,7 
(171.9-212.8) 
** 
5 24.3 
(13.9-40.2) 
27.1 
(22.6-35.2) 
Ns 153.5 
(121.8-213.6) 
192,9 
(183.7-214.2) 
* 
7 31.5 
(17.8-49.5) 
24.2 
(23.1-36.8) 
Ns 194.7 
(147.2-222.3) 
200 
(179.2-232.6) 
Ns 
8 44,8 
(30.9-58.8) 
26.7 
(23.2-33.6) 
** 341.9 
(239.1-404) 
186,7 
(165.7-218.3) 
** 
9 34.1 
(20.9-51.7) 
27.5 
(24.2-31.8) 
Ns 279.8 
(208.8-382.4) 
181,4 
(164.5-221) 
** 
10 27.7 
(20.4-56.8) 
30.5 
(25.1-32.4) 
Ns 192 
(156.4-242) 
192.4 
(154.7-234) 
Ns 
 
*: p < 0.05   **: p < 0.001  ***: p < 0.0001 
 
 
 
8.3 Discussion 
Although I have experienced neutrophilia in both groups, this phenomenon 
has proved more explicit in group A. This makes it clear that apart from the 
  
surgical trauma, which has been present in both groups, the effects of CPB 
resulting in an inflammatory response must also stand out.  
In this study the data have proved that the serum level of soluble adhesion 
molecules decreases in the ischaemic period of CPB. I have found no significant 
difference in the level of adhesion molecules in the control patients. I believe that 
due to the nature of the control group I have been successful in offering a straight 
and clear-cut view on the characteristics of soluble E-selectin and ICAM-1 actions 
during CPB and in the early postoperative period. 
My data confirm the theory that the artificial surface of CPB itself is also 
responsible for the inflammatory reaction following the use of CPB. Having said 
that a question still arises: why has the serum level of ICAM-1 and E selectin been 
decreased during CPB even in the corrected figures, too? I suppose that during the 
initial period of CPB the adhesion molecules are sequestrated either in the tissues 
of the lungs and liver or in the components of the artificial circulation (e.g. 
oxygenator membrane) It is also possible that the mentioned phenomenon is the 
result of increased adhesion of the adhesion molecules to activated neutrophils. 
The serum levels of soluble E-selectin 24 and 48 hours after CPB have 
reached and exceeded the level recorded before CPB but it has increased beyond 
the assumed values of the normal population in only two samples. I claim that the 
expression of adhesion molecules is a particular occurrence of CPB used during 
cardiac operations. Off pump surgery seems to be confirming this hypothesis. 
 
 
9 PULMONARY ALVEOLAR DAMAGE DURING CORONARY ARTERY 
GRAFTING WITH THE USE OF CPB. 
 
 
The aim of this study was to evaluate the microstructural effects of the use 
of contemporary CPB on the lungs and at the same time to assess the potential 
benefits of surgery without CPB. 
 
9.1 Patients and methods 
The study included 18 (15 males, 3 females) patients, aged 45-72 years, 
who underwent coronary artery bypass grafting. None of them had been previously 
treated for pulmonary disease. Two of the patients underwent OPCAB operation. 
Otherwise anaesthesia and surgical procedures were uniform, as I have previously 
described. In CPB procedures, the average time of aortic cross- clamping and 
bypass time was 58±14 and 101±13 minutes respectively. After sternotomy, lung 
biopsy was taken from the 4th segment of the left lung (specimen “A”) prior to the 
initiation of CPB and prior to performing the first distal coronary anastomoses in 
  
the OPCAB group. These biopsies served as control specimens of the basic 
histopathological findings before surgery. Immediately after the cessation of CPB 
and after the last coronary bypass was established in the OPCAB group, but before 
the chest was closed, another lung biopsy was obtained, proximate to the site of the 
first one (specimen "B"). The average size of biopsy specimens was approximately 
75 mm3. A control group of lung tissue specimens from 5 victims of traffic 
accidents who had no prior and/or underlying pulmonary disease was set up to 
determine the normal alveolar cellular constitution and the alveolar septum 
thickness values. 
 
9.1.1 Histologic processing: 
Biopsy specimens were fixed at room temperature in 4% formaline for 12 
to 16 hours. Citadel 2000 Shandon automated device was used for processing. 
Slices of 4µ thickness were stained by HE basic staining with Sakura Tissue TEK 
DRS device. Nikon Eclipse 800 microscope with built in; factory-fitted, 
standardised ocular micrometer was used for the microscopic measurement of the 
alveolar septum.  
In each HE stained slices we performed the measurement of 10 randomly 
chosen alveolar septum with 600x magnifying rate.  
Whenever the confirmation of the diagnosis was required, further special staining 
was applied. (Berlin blue, Gömöri silver, van-Gieson-Picosyrius). Occasionally 
immune-histochemical methods were also used to detect CD34, CD64, smooth 
muscle actin and vimentin. Further examinations were carried out with electron 
microscope on specimens taken from two randomly selected patients.  
 
9.2 Results: 
No serious pulmonary complication has developed in the postoperative 
period. All specimens have proved suitable for histologic evaluation. From 
biopsies taken before the initiation of CPB (specimen “A”) the diagnosis of the 
basic pulmonary histological status could be established and the findings could be 
classified into three main different diagnostic groups allowing intersection between 
the groups: 
1. Secondary pulmonary hypertension  
(12 cases, in 5 of those signs of severe disease) 
2. Emphysema 
(6 cases, 3 of them with signs of centroacinaer type) 
3. Interstitial fibrosis 
(8 cases, 3 of those with signs of severe disease) 
 
  
In 3 cases however histologic examination has found intact pulmonary 
tissue structure. Concerning specimens taken after the initiation of CPB the basic 
changes have naturally remained the same, however additional superimposed 
alterations could be observed. Light microscopic observations revealed only a few 
alterations in the structure of lung alveoli. Oedema as well as extravasated 
erythrocytes and neutrophils were present in specimens of six patients. Swelling of 
endothelial cells, of membranous pneumocytes, and of mitochondria in granular 
pneumocytes; interstitial haemorrhage (predominantly perivascular); engorgement 
of the pulmonary vascular bed; and miliary atelectasis are the histological features 
of pulmonary injury. These features were observed in some of the specimens. 
Frank oedema was present in some alveoli. In 12 patients who were operated with 
the use of CPB polymorphonuclear leukocytes accumulated within pulmonary 
capillaries during bypass. The accumulation of polymorphonuclear leukocytes was 
associated with the swelling of capillary endothelial cells and with the proliferation 
of type II granular pneumocytes. Reperfusion injury following ischaemia together 
with moderate passive hyperaemia and extravasated erythrocytes and neutrophils 
could be primarily detected.  
These alterations were accompanied by scarce appearance of proteins in 
the alveoli. Surprisingly enough the signs of ischaemia/reperfusion injury proved 
the most severe in 2 of those 3 patients who had intact pulmonary tissue structure 
before the starting of CPB. In those patients who underwent OPCAB surgery, none 
of the detrimental alterations mentioned above could be observed.  
The basic histopathological findings in "specimen A" biopsies and the 
alterations found in "specimen B" biopsies are summarised in Table 13. 
 
Alveolar thickness measured in the control group has proved 0.5-3.0 µm (Textbook 
data: 0.5-2.5 µm). For suitable understanding I use abbreviations to determine the 
followings: 
D1: mean alveolar thickness of biopsies of "specimen A". 
D2: mean alveolar thickness of biopsies of "specimen B" 
RD: average figure for the thickening. 
RD: average septum thickness increase. 
Light microscopy has revealed significant alveolar septum thickening 
(D1: 5.32 ± 1.51 µm vs. D2: 5.88 ± 1.33 µm, p = 0.04). RD of the alveolar septum 
has proved 1.14-fold (SD: 0.23). This equals an average increase (DD) of 0.55 µm 
(SD: 0.98). There has been no correlation between age and either the figure of D1, 
D2, DD and RD. 
Strong correlation could be observed however, between the figures of 
aortic cross clamp time and the degree of RD (R = 0.837, p < 0.001) and DD (R = 
0.833, p < 0.001). CPB duration showed another similar strong correlations with 
the degree of RD (R = 0.745, p = 0.001) and DD (R = 0.755, p = 0.001) 
  
 
Table 13.    Basic histopathological findings in the lung before CPB and 
alternations after CPB secession 
 
 
Specimen A Specimen B Case No
Normal PH Emphysema IF I/R Oedema 
1. +    ++  
2.  ++ +    
3.  ++   ++  
4.  +     
5.  +  + +  
6. +      
7.  ++     
8.  + ++   + 
9.  ++ + ++   
10.  +  +   
11.    ++  + 
12. +    ++  
13.    +  + 
14.  + ++   + 
15.  + + +  ++ 
16.  +  ++  ++ 
17.    +   
18.  ++ ++    
 
PH: Pulmonary Hypertension    IF: Interstitial fibrosis    I/R: 
Ischaemia/Reperfusion 
+: mild  ++: severe 
 
 
Investigating the basic histologic findings (results of biopsy specimens 
“A”) with the use of paired t probe we have found the followings: the presence or 
the absence of intact septum, pulmonary hypertension and interstitial fibrosis and 
the degree of these categories has not affected the figures of D1, D2, RD and DD. 
Otherwise the severity of emphysema has showed correlation with the figures of 
D1 (R = -0.537, p = 0.032) and D2 (R = -598, p = 0.014) but not with those of RD 
and DD. 
Electron microscopic findings confirmed the results of light microscopy. 
Moreover, in many alveoli, extensive injury to basal membrane of air-blood barrier 
  
was observed. Intravascular PMN's were found in increased numbers in the post 
CPB biopsy as compared to the pre-CPB biopsy. Intravascular PMN's were usually 
found in capillaries, where they appeared to fill the vessel lumen.  
Cytoplasmic swelling, mitochondrial swelling and swelling of the 
endoplasmic reticulum of PMN were not often seen. Nuclear abnormalities were 
not observed. PMN's were observed to be disintegrating intravascularly with 
release of PMN granules into the capillary lumen. Platelets were rarely seen in 
either the pre- or the post CPB biopsies. Endothelial and type I cell swelling was 
observed in some cells. Swelling of the endoplasmic reticulum and of the matrix 
compartment of mitochondria in type II granular pneumocytes was present. In 
many alveoli, surfactant was not homogeneously widespread and the cells 
producing it were swollen. Structures of pulmonary surfactant were present in the 
lumen of alveolar capillaries. 
 
9.3 Discussion 
The results of this investigation confirm, that even in the present era of 
cardiac surgery, cardiac operations with the use of all highly sophisticated 
technical equipment, myocardial protection and surgical approach (membrane 
oxygenator, normothermic surgery), CPB are still associated with positive signs of 
micro-structural damage and a degree of lung injury. In comparison with those 
structural damages found to occur in the early era of CPB, the degree of these 
alterations has certainly decreased. On the other hand this injury seems to be 
temporary because none of the investigated patients had any serious pulmonary 
complication in the postoperative course.  
My results suggest that the air-blood barrier becomes leaky after such 
procedures or even gets injured. Alveolar septum thickening seen in lung 
specimens taken after the ischaemic period might be explained with the 
accumulation of fluid and protein. The postulated mechanisms of such injury 
include neutrophil and complement activation, oxidative stress, lipid peroxidation 
or ischaemia-reperfusion injury. 
It is not surprising that I have been successful to statistically verify the 
significant correlation between the severity of lung injury and CPB duration. The 
reduction in the compliance of the lungs after CPB is well established. The 
observed interstitial oedema and haemorrhage as well as vascular congestion 
probably all contribute to this increase in stiffness by disturbing the fine balance 
between elasticity and structural rigidity of the lungs. The development of 
atelectasis after CPB is well documented, but the ethiology still remains 
controversial. Maybe that the observed injury to granular pneumocytes and the loss 
of surfactant activity contribute to the development of post CPB atelectasis. 
Although in this patient population there were only two cases operated without the 
use of CPB, findings from these cases clearly justify that no pulmonary 
  
ultrastructural injury has occurred during cardiac surgery without CPB. 
Surprisingly enough, my results indicate that the signs of ischaemia/reperfusion 
injury have proved more severe in 2 of those 3 patients who had intact pulmonary 
tissue structure before the initiation of CPB.  
A much clearer view could have been gained on the subject if specimens 
had been available e.g. on the 1st postoperative day or from patients who developed 
pulmonary complications in the postoperative period. Having said that certain 
ethical and technical considerations and limitations must be respected. 
The above observations provide strong evidence that CPB causes localised 
injuries to alveolar capillaries by damaging circulating polymorphonuclear 
leukocytes. Whether similar ultrastructural changes occur in systemic organs is not 
yet known. To assess the degree of lung injury, I suggest that, additional, 
quantitative studies are necessary. 
10 SUMMARY AND NEW RESULTS 
 
CPB is an invaluable tool for cardiac surgery ever since the 
heart has been operated on. Through the long years of its use 
certain side effects and drawbacks of the concept and the ever-
developing device have come into the limelight. By today there 
are two alternatives for the reduction of these negative 
attributes of CPB: either to improve the biocompatibility of the 
device and its accessories or to give up its use completely. 
Recently Cardiac Surgery has entered a new era and great 
emphasis seems to be taken on operating techniques without 
the use of CPB. After all, what future is to be expected for CPB? 
It is difficult to give a straight answer to this question, 
especially if the appearance of gene research and technique 
that might induce revolutionary changes in the field of Cardiac 
Surgery overall, is taken in consideration. Having said that, in 
my view, the use of CPB still remains on the cardiac surgical 
palette in the next future. Thus far it is only coronary surgery 
where CPB seems to be dispensable at all, while in other 
cardiac diseases there are no alternative techniques other than 
the use of CPB if surgery is to be performed.  
Immediately after the start of CPB, lung ischaemia occurs. 
This phenomenon has been justified with transpulmonary 
lactate ratio disturbances. During the ischaemic period, there 
is a considerable increase in activated neutrophil count in the 
lung tissue that could be verified with the measurement of the 
free radical production capacity of neutrophil cells. Histologic 
assessment of tissue specimens from the lungs after CPB has 
revealed gross neutrophil sequestration and alveolar basal 
membrane injury. 
My results have shown the kinetics of some elementary 
pro- and anti-inflammatory cytokines during CPB. The role of 
the lungs in these changes has also been revealed. Certainly, 
the drawback of the above investigations is the relatively small 
  
patient population. The only reason for that, is the financial 
burden associated with studies of this kind. In spite of this 
drawback, I am convinced that these results are suitable both 
for further comparative studies and for the investigation and 
assessment of the biocompatibility of newly developed 
oxygenators and CPB circuits. Deeper understanding of the, 
behaviour of and the role of cytokines and adhesion molecules 
during CPB may facilitate effective intervention in the 
inflammatory response process and suppression of its adverse 
effects and may can help in monitoring the efficacy of new 
therapeutic strategies. 
On the basis, of my results it has come clear that the lungs 
play an important role in the inflammatory response following 
operations on CPB. The lungs could be probably regarded as a 
“primary filter” or “primary guarding line” against those 
various jeopardising effects. 
In spite of the fact, that no thorough clinical investigation 
has been carried out to justify the difference between coronary 
artery bypass grafting operations with or without CPB, my 
study that consisted of a relatively small patient population has 
verified that concerning the inflammatory response there is a 
significant difference between the two groups. Investigation on 
the beneficial effects and outcome of “off-pump” surgery is still 
under way in my Department. 
 
 
 
 
 
 
All my results and primarily new observations are 
summarised below: 
 
  
1. I could prove that ARDS after CPB correlates with the 
duration of ischaemia and CPB. Blood and FFP transfusion 
are independent risk factors. 
 
2. I could show that, in spite of the use of partial CPB 
perfusion lung ischaemia has occurred and resulted in 
reperfusion injury. 
 
3. I have justified that notable lactate production occurs in the 
lungs during CPB. Two peaks of lactate values could be 
observed during and after CPB; one in the ischaemic 
period, the other one in the 2nd hour of reperfusion. 
 
4. I could certify that there is a transpulmonary neutrophil 
gradient and neutrophil sequestration in the lungs during 
CPB. 
 
5. Superoxide anion producing capacity of PMN cells during 
cardiac surgery with CPB is significantly increased in post-
pulmonary blood samples, hence I can suggest oxidative 
stress in the lungs during CPB. 
 
6. My observations support the idea, that there are significant 
fluctuations in the levels of serum IL-6, IL-8, and IL-10 
occurring during CPB. 
 
7. Concerning alterations of IL-8 and IL-10, I suggest that, the 
lungs consume rather than, produce these substances and 
IL-10 changes show a positive correlation with favourable 
haemodynamic variables. 
 
8. I could not justify any role for IL-2 during CPB although 
this interleukin is held responsible for certain lung 
diseases. 
 
  
9. I have verified that expression of E-selectin and ICAM-1 is a 
particular occurrence of CPB. This observation has failed in 
OPCAB surgery. 
 
10. Light and electron microscopic histology observations of 
the lung tissue after CPB suggest relevant cellular damage. I 
have revealed that there is an alveolar septum thickness 
increase after cardiac surgery carried out on CPB and this 
increase strongly correlates with the duration of ischaemia 
and CPB. 
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